

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.49594763 |
| 2 | negative regulation of cell killing (GO:0031342) | 7.49594763 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.11366074 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.88023620 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.88023620 |
| 6 | negative T cell selection (GO:0043383) | 6.62362400 |
| 7 | positive thymic T cell selection (GO:0045059) | 6.52736424 |
| 8 | negative thymic T cell selection (GO:0045060) | 6.46040174 |
| 9 | DNA strand renaturation (GO:0000733) | 6.40271753 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.18086027 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.06058041 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.04298522 |
| 13 | positive T cell selection (GO:0043368) | 5.80963297 |
| 14 | thymic T cell selection (GO:0045061) | 5.72012190 |
| 15 | response to interleukin-15 (GO:0070672) | 5.68213471 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 5.51312975 |
| 17 | cellular response to interleukin-15 (GO:0071350) | 5.41407075 |
| 18 | positive regulation of antigen processing and presentation (GO:0002579) | 5.41314470 |
| 19 | interferon-gamma production (GO:0032609) | 5.35343177 |
| 20 | negative regulation of bone resorption (GO:0045779) | 5.33656801 |
| 21 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.26891661 |
| 22 | T cell selection (GO:0045058) | 5.22190381 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.13145466 |
| 24 | leukocyte aggregation (GO:0070486) | 5.06992181 |
| 25 | tolerance induction (GO:0002507) | 4.70588265 |
| 26 | * T cell migration (GO:0072678) | 4.68939358 |
| 27 | T cell receptor signaling pathway (GO:0050852) | 4.65202661 |
| 28 | negative regulation of B cell proliferation (GO:0030889) | 4.53527634 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.47176802 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 4.47176802 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 4.47176802 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 4.47176802 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.47176802 |
| 34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.47176802 |
| 35 | negative regulation of granulocyte differentiation (GO:0030853) | 4.43580056 |
| 36 | regulation of antigen processing and presentation (GO:0002577) | 4.39985603 |
| 37 | T cell costimulation (GO:0031295) | 4.35553162 |
| 38 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.32955261 |
| 39 | lymphocyte costimulation (GO:0031294) | 4.28534556 |
| 40 | regulation of T cell tolerance induction (GO:0002664) | 4.26028525 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.23929927 |
| 42 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.17125376 |
| 43 | apoptotic cell clearance (GO:0043277) | 4.16019794 |
| 44 | negative regulation of bone remodeling (GO:0046851) | 4.13423319 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 4.07372240 |
| 46 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.05438465 |
| 47 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.04542877 |
| 48 | activated T cell proliferation (GO:0050798) | 3.98690895 |
| 49 | positive regulation of protein export from nucleus (GO:0046827) | 3.98303772 |
| 50 | B cell homeostasis (GO:0001782) | 3.92053432 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 3.91673367 |
| 52 | sequestering of actin monomers (GO:0042989) | 3.90714553 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.89498932 |
| 54 | T-helper cell differentiation (GO:0042093) | 3.78183025 |
| 55 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.78183025 |
| 56 | mast cell activation (GO:0045576) | 3.74427484 |
| 57 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.74015672 |
| 58 | regulation of B cell differentiation (GO:0045577) | 3.73475034 |
| 59 | B cell receptor signaling pathway (GO:0050853) | 3.71468041 |
| 60 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.71315057 |
| 61 | peptidyl-lysine dimethylation (GO:0018027) | 3.70481482 |
| 62 | positive regulation of isotype switching (GO:0045830) | 3.68469035 |
| 63 | positive regulation of tolerance induction (GO:0002645) | 3.67340304 |
| 64 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.66655240 |
| 65 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.63634108 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 3.60094768 |
| 67 | regulation of granulocyte differentiation (GO:0030852) | 3.56593131 |
| 68 | negative regulation of tissue remodeling (GO:0034104) | 3.54157616 |
| 69 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.51023976 |
| 70 | regulation of response to interferon-gamma (GO:0060330) | 3.48876769 |
| 71 | regulation of B cell proliferation (GO:0030888) | 3.47048873 |
| 72 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.46455107 |
| 73 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.45421708 |
| 74 | * leukocyte cell-cell adhesion (GO:0007159) | 3.44113513 |
| 75 | mitotic nuclear envelope reassembly (GO:0007084) | 3.41707667 |
| 76 | nuclear envelope reassembly (GO:0031468) | 3.41707667 |
| 77 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.38234116 |
| 78 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.38234116 |
| 79 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.37613539 |
| 80 | Peyers patch development (GO:0048541) | 3.37613539 |
| 81 | regulation of isotype switching (GO:0045191) | 3.37178381 |
| 82 | regulation of regulatory T cell differentiation (GO:0045589) | 3.36878142 |
| 83 | regulation of monocyte differentiation (GO:0045655) | 3.36447522 |
| 84 | negative regulation of necroptotic process (GO:0060546) | 3.35934131 |
| 85 | regulation of necroptotic process (GO:0060544) | 3.33886757 |
| 86 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.33767707 |
| 87 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.32698602 |
| 88 | B cell mediated immunity (GO:0019724) | 3.29222926 |
| 89 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.29123972 |
| 90 | T cell differentiation involved in immune response (GO:0002292) | 3.28756921 |
| 91 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.28756921 |
| 92 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.28756921 |
| 93 | mannose metabolic process (GO:0006013) | 3.26383839 |
| 94 | response to muramyl dipeptide (GO:0032495) | 3.25186922 |
| 95 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.24603426 |
| 96 | mast cell activation involved in immune response (GO:0002279) | 3.24346307 |
| 97 | mast cell degranulation (GO:0043303) | 3.24346307 |
| 98 | positive regulation of interleukin-2 production (GO:0032743) | 3.24183669 |
| 99 | positive regulation of DNA recombination (GO:0045911) | 3.21625579 |
| 100 | hepatocyte apoptotic process (GO:0097284) | 3.21563026 |
| 101 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.19661578 |
| 102 | regulation of tolerance induction (GO:0002643) | 3.19358139 |
| 103 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.18532288 |
| 104 | NIK/NF-kappaB signaling (GO:0038061) | 3.17524722 |
| 105 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.16432341 |
| 106 | negative regulation of interleukin-12 production (GO:0032695) | 3.15993258 |
| 107 | cellular extravasation (GO:0045123) | 3.13938399 |
| 108 | natural killer cell activation (GO:0030101) | 3.13137906 |
| 109 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.12181312 |
| 110 | positive regulation of lamellipodium assembly (GO:0010592) | 3.12104403 |
| 111 | determination of adult lifespan (GO:0008340) | 3.10879180 |
| 112 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.10619225 |
| 113 | positive regulation of immunoglobulin production (GO:0002639) | 3.10056151 |
| 114 | positive regulation of B cell mediated immunity (GO:0002714) | 3.07645224 |
| 115 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.07645224 |
| 116 | positive regulation of interferon-alpha production (GO:0032727) | 3.07311864 |
| 117 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.07199142 |
| 118 | negative regulation of interleukin-6 production (GO:0032715) | 3.07041907 |
| 119 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.06347112 |
| 120 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.03277575 |
| 121 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.03128919 |
| 122 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.03128919 |
| 123 | T cell homeostasis (GO:0043029) | 3.01653130 |
| 124 | cellular response to zinc ion (GO:0071294) | 3.01048437 |
| 125 | response to type I interferon (GO:0034340) | 3.00106612 |
| 126 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.99975502 |
| 127 | T cell differentiation (GO:0030217) | 2.99511412 |
| 128 | positive regulation of B cell differentiation (GO:0045579) | 2.98365492 |
| 129 | regulation of B cell mediated immunity (GO:0002712) | 2.96613037 |
| 130 | alpha-beta T cell activation (GO:0046631) | 2.96372946 |
| 131 | cellular response to type I interferon (GO:0071357) | 2.94675569 |
| 132 | type I interferon signaling pathway (GO:0060337) | 2.94675569 |
| 133 | response to peptidoglycan (GO:0032494) | 2.94662379 |
| 134 | regulation of immunoglobulin production (GO:0002637) | 2.93742706 |
| 135 | positive regulation of B cell activation (GO:0050871) | 2.91930717 |
| 136 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91208225 |
| 137 | response to host immune response (GO:0052572) | 2.91208225 |
| 138 | T cell activation (GO:0042110) | 2.91197935 |
| 139 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.90519035 |
| 140 | negative regulation of catenin import into nucleus (GO:0035414) | 2.90207142 |
| 141 | lymphocyte homeostasis (GO:0002260) | 2.90123296 |
| 142 | regulation of defense response to virus by virus (GO:0050690) | 2.87440124 |
| 143 | N-acetylneuraminate metabolic process (GO:0006054) | 2.86772623 |
| 144 | neutrophil activation involved in immune response (GO:0002283) | 2.86379421 |
| 145 | regulation of interferon-alpha production (GO:0032647) | 2.85774483 |
| 146 | T cell proliferation (GO:0042098) | 2.85484497 |
| 147 | positive regulation of granulocyte differentiation (GO:0030854) | 2.85319289 |
| 148 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.83804630 |
| 149 | positive regulation of humoral immune response (GO:0002922) | 2.83087209 |
| 150 | regulation of cell killing (GO:0031341) | 2.82508136 |
| 151 | regulation of ARF protein signal transduction (GO:0032012) | 2.82318345 |
| 152 | lymphocyte chemotaxis (GO:0048247) | 2.82153798 |
| 153 | germinal center formation (GO:0002467) | 2.80933420 |
| 154 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.80215448 |
| 155 | negative regulation of phagocytosis (GO:0050765) | 2.79675627 |
| 156 | alpha-beta T cell differentiation (GO:0046632) | 2.78459563 |
| 157 | mitochondrion distribution (GO:0048311) | 2.77964040 |
| 158 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.77420346 |
| 159 | regulation of activation of Janus kinase activity (GO:0010533) | 2.71435793 |
| 160 | regulation of B cell activation (GO:0050864) | 2.68735207 |
| 161 | negative regulation of necrotic cell death (GO:0060547) | 2.67416024 |
| 162 | response to host defenses (GO:0052200) | 2.63818976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.83389971 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.94591639 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.99906678 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.65391820 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.31034891 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.20491363 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13159010 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.99906698 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.97380061 |
| 10 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.94489464 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.88779279 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.88772368 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.88495903 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.83604308 |
| 15 | * MAF_26560356_Chip-Seq_TH1_Human | 2.82023730 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.79689160 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.69534347 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.58975338 |
| 19 | * MYB_26560356_Chip-Seq_TH1_Human | 2.52923834 |
| 20 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44096141 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.29932220 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.29839179 |
| 23 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.28506506 |
| 24 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.11751339 |
| 25 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.05570242 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05318694 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.03128036 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.02791688 |
| 29 | * MAF_26560356_Chip-Seq_TH2_Human | 2.02356012 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.02216768 |
| 31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.01539868 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98932616 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.98498097 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95345476 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.92619993 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.84510756 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83818274 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83624959 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.82418467 |
| 40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.81037849 |
| 41 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.79212610 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79021943 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76483389 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67428155 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66924475 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64808378 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.59460310 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59287656 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57301819 |
| 50 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.57088788 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49698090 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49072197 |
| 53 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.45940114 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45745212 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43307519 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41496283 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33281826 |
| 58 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.28540509 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26576704 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23573950 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23506170 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22387208 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22090744 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20569743 |
| 65 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19645785 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.19613423 |
| 67 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17573182 |
| 68 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16455486 |
| 69 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16189991 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12951284 |
| 71 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12923116 |
| 72 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.12414251 |
| 73 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11946158 |
| 74 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09960781 |
| 75 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.09123929 |
| 76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08878655 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08711755 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08155561 |
| 79 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08065881 |
| 80 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.07782198 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07537588 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06702543 |
| 83 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06319387 |
| 84 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06021140 |
| 85 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01934679 |
| 86 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.01933189 |
| 87 | P68_20966046_ChIP-Seq_HELA_Human | 1.01761618 |
| 88 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99202649 |
| 89 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98536020 |
| 90 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97161897 |
| 91 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96652767 |
| 92 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96017691 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95524154 |
| 94 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.94519256 |
| 95 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.94390622 |
| 96 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94086077 |
| 97 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94059023 |
| 98 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.93243204 |
| 99 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.91565977 |
| 100 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91129375 |
| 101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90951324 |
| 102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90565908 |
| 103 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87692355 |
| 104 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87583234 |
| 105 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87504240 |
| 106 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.87390891 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87155292 |
| 108 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.86905279 |
| 109 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86333383 |
| 110 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.84553752 |
| 111 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.84125981 |
| 112 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.83768731 |
| 113 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83078371 |
| 114 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81817905 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81327623 |
| 116 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.80264583 |
| 117 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.77333511 |
| 118 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.76246427 |
| 119 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.75975484 |
| 120 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75866265 |
| 121 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.75654042 |
| 122 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.74825189 |
| 123 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.74533428 |
| 124 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.74250991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.86164431 |
| 2 | MP0005671_abnormal_response_to | 3.94826837 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.62340242 |
| 4 | MP0001800_abnormal_humoral_immune | 3.27768182 |
| 5 | * MP0000685_abnormal_immune_system | 3.22595519 |
| 6 | * MP0001790_abnormal_immune_system | 2.95620703 |
| 7 | * MP0005387_immune_system_phenotype | 2.95620703 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.90705355 |
| 9 | * MP0002420_abnormal_adaptive_immunity | 2.86752704 |
| 10 | * MP0001819_abnormal_immune_cell | 2.83339447 |
| 11 | MP0002723_abnormal_immune_serum | 2.83100859 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.82410138 |
| 13 | * MP0002398_abnormal_bone_marrow | 2.80740466 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.75997573 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.72906700 |
| 16 | MP0002405_respiratory_system_inflammati | 2.57870401 |
| 17 | MP0003436_decreased_susceptibility_to | 2.54821745 |
| 18 | MP0001873_stomach_inflammation | 2.54207361 |
| 19 | MP0009785_altered_susceptibility_to | 2.53167311 |
| 20 | * MP0005025_abnormal_response_to | 2.52140849 |
| 21 | * MP0000716_abnormal_immune_system | 2.46520821 |
| 22 | MP0006082_CNS_inflammation | 2.45366114 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.41922378 |
| 24 | MP0003878_abnormal_ear_physiology | 2.40678301 |
| 25 | MP0005377_hearing/vestibular/ear_phenot | 2.40678301 |
| 26 | MP0000703_abnormal_thymus_morphology | 2.38331382 |
| 27 | MP0004043_abnormal_pH_regulation | 2.35471844 |
| 28 | * MP0002722_abnormal_immune_system | 2.30749431 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.30411402 |
| 30 | MP0002006_tumorigenesis | 2.29532227 |
| 31 | MP0005464_abnormal_platelet_physiology | 2.12282840 |
| 32 | MP0002419_abnormal_innate_immunity | 2.11614793 |
| 33 | MP0003866_abnormal_defecation | 2.11303437 |
| 34 | MP0004947_skin_inflammation | 2.11169709 |
| 35 | * MP0002429_abnormal_blood_cell | 2.05111048 |
| 36 | MP0003303_peritoneal_inflammation | 2.01954900 |
| 37 | * MP0010155_abnormal_intestine_physiology | 2.00559330 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.99811469 |
| 39 | MP0003724_increased_susceptibility_to | 1.98196060 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.97205281 |
| 41 | MP0004510_myositis | 1.87243642 |
| 42 | MP0005451_abnormal_body_composition | 1.85149690 |
| 43 | * MP0001845_abnormal_inflammatory_respons | 1.71641679 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.56093320 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.54994379 |
| 46 | MP0009278_abnormal_bone_marrow | 1.54563272 |
| 47 | MP0001853_heart_inflammation | 1.52975227 |
| 48 | MP0000858_altered_metastatic_potential | 1.46437697 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.46391135 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.46391135 |
| 51 | MP0002009_preneoplasia | 1.44939548 |
| 52 | MP0002638_abnormal_pupillary_reflex | 1.44727174 |
| 53 | MP0000490_abnormal_crypts_of | 1.44197338 |
| 54 | MP0008057_abnormal_DNA_replication | 1.42366688 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.42159671 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.40076084 |
| 57 | MP0002102_abnormal_ear_morphology | 1.33857542 |
| 58 | MP0005310_abnormal_salivary_gland | 1.33686622 |
| 59 | MP0003879_abnormal_hair_cell | 1.29174096 |
| 60 | MP0003448_altered_tumor_morphology | 1.28961847 |
| 61 | MP0002089_abnormal_postnatal_growth/wei | 1.22939553 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.19809018 |
| 63 | * MP0002933_joint_inflammation | 1.19794341 |
| 64 | MP0002019_abnormal_tumor_incidence | 1.18573962 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.16914515 |
| 66 | MP0001348_abnormal_lacrimal_gland | 1.15866925 |
| 67 | MP0008469_abnormal_protein_level | 1.15755540 |
| 68 | MP0001533_abnormal_skeleton_physiology | 1.14422481 |
| 69 | MP0008995_early_reproductive_senescence | 1.12885244 |
| 70 | MP0008569_lethality_at_weaning | 1.12687991 |
| 71 | MP0001851_eye_inflammation | 1.10078025 |
| 72 | MP0003045_fibrosis | 1.09186493 |
| 73 | MP0002132_abnormal_respiratory_system | 1.08022984 |
| 74 | MP0009840_abnormal_foam_cell | 1.06923247 |
| 75 | MP0005058_abnormal_lysosome_morphology | 1.01872259 |
| 76 | MP0008260_abnormal_autophagy | 0.98839307 |
| 77 | MP0004264_abnormal_extraembryonic_tissu | 0.92222521 |
| 78 | MP0005023_abnormal_wound_healing | 0.90463776 |
| 79 | MP0005220_abnormal_exocrine_pancreas | 0.90441940 |
| 80 | MP0003077_abnormal_cell_cycle | 0.88088434 |
| 81 | MP0002163_abnormal_gland_morphology | 0.87431969 |
| 82 | MP0005076_abnormal_cell_differentiation | 0.87285631 |
| 83 | MP0002998_abnormal_bone_remodeling | 0.84725891 |
| 84 | MP0004381_abnormal_hair_follicle | 0.84382237 |
| 85 | MP0004742_abnormal_vestibular_system | 0.83331694 |
| 86 | MP0002138_abnormal_hepatobiliary_system | 0.80797432 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.80422155 |
| 88 | MP0000015_abnormal_ear_pigmentation | 0.79443796 |
| 89 | MP0005423_abnormal_somatic_nervous | 0.78929097 |
| 90 | MP0002693_abnormal_pancreas_physiology | 0.78449057 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.77456609 |
| 92 | MP0002332_abnormal_exercise_endurance | 0.72154913 |
| 93 | MP0003693_abnormal_embryo_hatching | 0.72042732 |
| 94 | MP0010094_abnormal_chromosome_stability | 0.71874141 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.70862866 |
| 96 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70649607 |
| 97 | MP0005171_absent_coat_pigmentation | 0.70218242 |
| 98 | MP0008004_abnormal_stomach_pH | 0.69983351 |
| 99 | MP0000477_abnormal_intestine_morphology | 0.69107875 |
| 100 | MP0010307_abnormal_tumor_latency | 0.67305812 |
| 101 | MP0009763_increased_sensitivity_to | 0.66415852 |
| 102 | MP0005381_digestive/alimentary_phenotyp | 0.65498963 |
| 103 | MP0004957_abnormal_blastocyst_morpholog | 0.64725802 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.63248476 |
| 105 | MP0010234_abnormal_vibrissa_follicle | 0.62649812 |
| 106 | MP0000371_diluted_coat_color | 0.62042269 |
| 107 | MP0001919_abnormal_reproductive_system | 0.59686578 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.59224382 |
| 109 | MP0000343_altered_response_to | 0.58501172 |
| 110 | MP0003111_abnormal_nucleus_morphology | 0.58120019 |
| 111 | MP0000313_abnormal_cell_death | 0.57540346 |
| 112 | MP0001663_abnormal_digestive_system | 0.54695186 |
| 113 | MP0003828_pulmonary_edema | 0.54631260 |
| 114 | MP0000609_abnormal_liver_physiology | 0.54353257 |
| 115 | MP0008058_abnormal_DNA_repair | 0.54202130 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.54177108 |
| 117 | MP0000920_abnormal_myelination | 0.52968309 |
| 118 | MP0003183_abnormal_peptide_metabolism | 0.52342046 |
| 119 | MP0002083_premature_death | 0.52190881 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.51267264 |
| 121 | MP0000249_abnormal_blood_vessel | 0.48976183 |
| 122 | MP0005390_skeleton_phenotype | 0.48228976 |
| 123 | MP0005166_decreased_susceptibility_to | 0.48186774 |
| 124 | MP0003795_abnormal_bone_structure | 0.48182789 |
| 125 | MP0008873_increased_physiological_sensi | 0.44692201 |
| 126 | MP0000350_abnormal_cell_proliferation | 0.44327373 |
| 127 | MP0009764_decreased_sensitivity_to | 0.43374644 |
| 128 | MP0003091_abnormal_cell_migration | 0.43271092 |
| 129 | MP0003191_abnormal_cellular_cholesterol | 0.42606221 |
| 130 | * MP0002086_abnormal_extraembryonic_tissu | 0.42226769 |
| 131 | MP0002095_abnormal_skin_pigmentation | 0.41942489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.98178696 |
| 2 | Decreased circulating renin level (HP:0003351) | 5.68783842 |
| 3 | Abnormality of T cell number (HP:0011839) | 5.68560315 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 5.64330589 |
| 5 | IgM deficiency (HP:0002850) | 5.17579783 |
| 6 | Pustule (HP:0200039) | 5.17024670 |
| 7 | Nasal polyposis (HP:0100582) | 5.10573280 |
| 8 | Recurrent bronchitis (HP:0002837) | 4.99217408 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.93646233 |
| 10 | Abnormality of T cells (HP:0002843) | 4.92909491 |
| 11 | Chronic otitis media (HP:0000389) | 4.82827130 |
| 12 | Hypokalemic alkalosis (HP:0001949) | 4.60136382 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.54863960 |
| 14 | Abnormality of the nasal mucosa (HP:0000433) | 4.35293644 |
| 15 | Myositis (HP:0100614) | 4.31326202 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.26714685 |
| 17 | Nuclear cataract (HP:0100018) | 4.22211151 |
| 18 | Eczematoid dermatitis (HP:0000976) | 4.18623483 |
| 19 | Stomatitis (HP:0010280) | 4.11314077 |
| 20 | Achilles tendon contracture (HP:0001771) | 4.09592110 |
| 21 | Recurrent viral infections (HP:0004429) | 4.06115783 |
| 22 | Severe combined immunodeficiency (HP:0004430) | 3.98628859 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.98609991 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.98609991 |
| 25 | Combined immunodeficiency (HP:0005387) | 3.91864642 |
| 26 | Panhypogammaglobulinemia (HP:0003139) | 3.87386421 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 3.85875796 |
| 28 | Recurrent abscess formation (HP:0002722) | 3.83567001 |
| 29 | IgG deficiency (HP:0004315) | 3.81876694 |
| 30 | Large eyes (HP:0001090) | 3.72710271 |
| 31 | Hyperkalemia (HP:0002153) | 3.68630687 |
| 32 | Abnormality of the Achilles tendon (HP:0005109) | 3.67649812 |
| 33 | Chronic bronchitis (HP:0004469) | 3.53205002 |
| 34 | Increased IgM level (HP:0003496) | 3.49807156 |
| 35 | Inflammation of the large intestine (HP:0002037) | 3.46776312 |
| 36 | Gastrointestinal inflammation (HP:0004386) | 3.36419137 |
| 37 | Zonular cataract (HP:0010920) | 3.21409997 |
| 38 | Lymphopenia (HP:0001888) | 3.16876721 |
| 39 | Meningitis (HP:0001287) | 3.13576621 |
| 40 | Muscle fiber atrophy (HP:0100295) | 3.09913283 |
| 41 | Hyponatremia (HP:0002902) | 3.09162831 |
| 42 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.06857337 |
| 43 | Spontaneous hematomas (HP:0007420) | 3.04771265 |
| 44 | Abnormality of the fingertips (HP:0001211) | 3.01887962 |
| 45 | Abnormality of eosinophils (HP:0001879) | 3.01157457 |
| 46 | IgA deficiency (HP:0002720) | 3.00512026 |
| 47 | Recurrent skin infections (HP:0001581) | 2.97615481 |
| 48 | Leukocytosis (HP:0001974) | 2.96889210 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.96498938 |
| 50 | Optic neuritis (HP:0100653) | 2.96498938 |
| 51 | Abnormality of incisor morphology (HP:0011063) | 2.94189686 |
| 52 | Basal cell carcinoma (HP:0002671) | 2.92754924 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.91715489 |
| 54 | Orchitis (HP:0100796) | 2.91367530 |
| 55 | Thyroiditis (HP:0100646) | 2.91297197 |
| 56 | Recurrent bacterial skin infections (HP:0005406) | 2.91220079 |
| 57 | Autoimmune hemolytic anemia (HP:0001890) | 2.86842967 |
| 58 | Premature loss of primary teeth (HP:0006323) | 2.86808803 |
| 59 | Atrioventricular block (HP:0001678) | 2.85438801 |
| 60 | Obstructive lung disease (HP:0006536) | 2.84723991 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84723991 |
| 62 | Vasculitis (HP:0002633) | 2.81748941 |
| 63 | Colitis (HP:0002583) | 2.81192196 |
| 64 | Conical tooth (HP:0000698) | 2.80981120 |
| 65 | Increased IgE level (HP:0003212) | 2.80044741 |
| 66 | Onycholysis (HP:0001806) | 2.74664247 |
| 67 | Chronic diarrhea (HP:0002028) | 2.73994710 |
| 68 | Agammaglobulinemia (HP:0004432) | 2.73753150 |
| 69 | Bronchitis (HP:0012387) | 2.73137194 |
| 70 | Mediastinal lymphadenopathy (HP:0100721) | 2.72700608 |
| 71 | Recurrent sinusitis (HP:0011108) | 2.72088638 |
| 72 | Renal salt wasting (HP:0000127) | 2.71530402 |
| 73 | Encephalitis (HP:0002383) | 2.71111259 |
| 74 | Cone-rod dystrophy (HP:0000548) | 2.69850139 |
| 75 | Dry hair (HP:0011359) | 2.66271801 |
| 76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.64692281 |
| 77 | Petechiae (HP:0000967) | 2.64373458 |
| 78 | Abnormality of renin-angiotensin system (HP:0000847) | 2.60751058 |
| 79 | Hypergammaglobulinemia (HP:0010702) | 2.58462844 |
| 80 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.57134509 |
| 81 | Hemoptysis (HP:0002105) | 2.57095063 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.56834485 |
| 83 | Abnormality of B cell number (HP:0010975) | 2.55801819 |
| 84 | B lymphocytopenia (HP:0010976) | 2.55801819 |
| 85 | Eosinophilia (HP:0001880) | 2.55303900 |
| 86 | Lymphoma (HP:0002665) | 2.55062167 |
| 87 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.54522336 |
| 88 | Autoimmune thrombocytopenia (HP:0001973) | 2.54321505 |
| 89 | Abnormal platelet volume (HP:0011876) | 2.53776160 |
| 90 | Hyperaldosteronism (HP:0000859) | 2.53387908 |
| 91 | Epistaxis (HP:0000421) | 2.52074824 |
| 92 | Joint swelling (HP:0001386) | 2.51305757 |
| 93 | Erythema (HP:0010783) | 2.50992712 |
| 94 | Poikiloderma (HP:0001029) | 2.48523836 |
| 95 | Flat capital femoral epiphysis (HP:0003370) | 2.47568324 |
| 96 | Overlapping toe (HP:0001845) | 2.46407459 |
| 97 | Verrucae (HP:0200043) | 2.45740651 |
| 98 | Papilloma (HP:0012740) | 2.45740651 |
| 99 | Cheilitis (HP:0100825) | 2.41647266 |
| 100 | Pulmonary infiltrates (HP:0002113) | 2.41445092 |
| 101 | Urticaria (HP:0001025) | 2.41010850 |
| 102 | Chronic sinusitis (HP:0011109) | 2.40176882 |
| 103 | Abnormality of chloride homeostasis (HP:0011422) | 2.36280035 |
| 104 | Joint contractures involving the joints of the feet (HP:0100492) | 2.35997833 |
| 105 | Flexion contracture of toe (HP:0005830) | 2.35997833 |
| 106 | Thrombocytosis (HP:0001894) | 2.35630710 |
| 107 | Acute hepatic failure (HP:0006554) | 2.34407110 |
| 108 | Granulocytopenia (HP:0001913) | 2.34196075 |
| 109 | Alkalosis (HP:0001948) | 2.28812107 |
| 110 | Gingival bleeding (HP:0000225) | 2.21617274 |
| 111 | Gastrointestinal infarctions (HP:0005244) | 2.21307362 |
| 112 | Basal ganglia calcification (HP:0002135) | 2.20047648 |
| 113 | Shawl scrotum (HP:0000049) | 2.18916463 |
| 114 | Abnormality of sodium homeostasis (HP:0010931) | 2.18646717 |
| 115 | Arterial thrombosis (HP:0004420) | 2.16389205 |
| 116 | Cellulitis (HP:0100658) | 2.15696933 |
| 117 | Increased density of long bones (HP:0006392) | 2.14544378 |
| 118 | Keratoconjunctivitis sicca (HP:0001097) | 2.14073754 |
| 119 | Elbow flexion contracture (HP:0002987) | 2.13805216 |
| 120 | Abnormality of macrophages (HP:0004311) | 2.13038518 |
| 121 | Ridged nail (HP:0001807) | 2.11218019 |
| 122 | Emphysema (HP:0002097) | 2.10275380 |
| 123 | Prominent nose (HP:0000448) | 2.09726872 |
| 124 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.07566926 |
| 125 | Progressive visual loss (HP:0000529) | 2.06578256 |
| 126 | Chest pain (HP:0100749) | 2.06114579 |
| 127 | Blepharitis (HP:0000498) | 2.05978477 |
| 128 | Trismus (HP:0000211) | 2.04645914 |
| 129 | Recurrent otitis media (HP:0000403) | 2.04264463 |
| 130 | J-shaped sella turcica (HP:0002680) | 2.01919051 |
| 131 | Viral hepatitis (HP:0006562) | 2.01244928 |
| 132 | Hypoplasia of the thymus (HP:0000778) | 1.99895414 |
| 133 | Pulmonary embolism (HP:0002204) | 1.99624791 |
| 134 | Skin ulcer (HP:0200042) | 1.99509127 |
| 135 | Albinism (HP:0001022) | 1.98873131 |
| 136 | Squamous cell carcinoma (HP:0002860) | 1.96810207 |
| 137 | Skin rash (HP:0000988) | 1.95811316 |
| 138 | Increased mean platelet volume (HP:0011877) | 1.94821190 |
| 139 | Gingivitis (HP:0000230) | 1.92476216 |
| 140 | Keratoconjunctivitis (HP:0001096) | 1.91651202 |
| 141 | Microcytic anemia (HP:0001935) | 1.91236860 |
| 142 | Abnormality of the prostate (HP:0008775) | 1.90071611 |
| 143 | Gastrointestinal stroma tumor (HP:0100723) | 1.89645080 |
| 144 | Subacute progressive viral hepatitis (HP:0006572) | 1.89416020 |
| 145 | Dysostosis multiplex (HP:0000943) | 1.86413485 |
| 146 | Interstitial pulmonary disease (HP:0006530) | 1.85674308 |
| 147 | Anorexia (HP:0002039) | 1.85124794 |
| 148 | Bronchiectasis (HP:0002110) | 1.84512103 |
| 149 | Periodontitis (HP:0000704) | 1.82392696 |
| 150 | Impaired platelet aggregation (HP:0003540) | 1.78892664 |
| 151 | Abnormal platelet function (HP:0011869) | 1.78892664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.22768132 |
| 2 | PRPF4B | 4.87423616 |
| 3 | TXK | 4.65971854 |
| 4 | MOS | 3.38216136 |
| 5 | ZAP70 | 3.04005198 |
| 6 | GRK7 | 2.97679323 |
| 7 | JAK3 | 2.95558584 |
| 8 | STK10 | 2.72901169 |
| 9 | ITK | 2.71977011 |
| 10 | TYK2 | 2.63572610 |
| 11 | GRK6 | 2.63300070 |
| 12 | FGFR4 | 2.45861123 |
| 13 | IKBKE | 2.26560671 |
| 14 | CSK | 2.12505047 |
| 15 | JAK1 | 2.07706047 |
| 16 | BLK | 1.89581439 |
| 17 | LCK | 1.82751611 |
| 18 | EEF2K | 1.72304963 |
| 19 | TBK1 | 1.72293806 |
| 20 | TESK2 | 1.71929359 |
| 21 | KIT | 1.62925045 |
| 22 | MAP3K10 | 1.60459538 |
| 23 | NME2 | 1.56734182 |
| 24 | BTK | 1.56662783 |
| 25 | SMG1 | 1.55519444 |
| 26 | SYK | 1.51220300 |
| 27 | RIPK4 | 1.49783439 |
| 28 | FGFR3 | 1.47570171 |
| 29 | MAP3K14 | 1.45460848 |
| 30 | TEC | 1.45057691 |
| 31 | NLK | 1.44963239 |
| 32 | SIK1 | 1.44009062 |
| 33 | HCK | 1.37416644 |
| 34 | MAP3K13 | 1.34698445 |
| 35 | PKN2 | 1.32557343 |
| 36 | KDR | 1.32407819 |
| 37 | IRAK4 | 1.31472449 |
| 38 | PIM1 | 1.27373222 |
| 39 | GRK5 | 1.25518527 |
| 40 | TRIB3 | 1.19960189 |
| 41 | RAF1 | 1.19542323 |
| 42 | LRRK2 | 1.19033058 |
| 43 | MARK3 | 1.19031836 |
| 44 | IKBKB | 1.12716548 |
| 45 | SIK2 | 1.12213830 |
| 46 | MAP3K11 | 1.10873307 |
| 47 | TNK2 | 1.04378027 |
| 48 | FES | 1.04048972 |
| 49 | CSF1R | 0.99163805 |
| 50 | PRKCH | 0.97831039 |
| 51 | MST4 | 0.97676743 |
| 52 | TYRO3 | 0.95869948 |
| 53 | MAPK12 | 0.93865990 |
| 54 | JAK2 | 0.93805378 |
| 55 | CLK1 | 0.93751228 |
| 56 | PRKD2 | 0.93477504 |
| 57 | LYN | 0.93017654 |
| 58 | IRAK2 | 0.92970475 |
| 59 | KSR2 | 0.89869302 |
| 60 | FLT3 | 0.88635169 |
| 61 | EPHB1 | 0.86769001 |
| 62 | RPS6KA4 | 0.85792673 |
| 63 | MAP2K3 | 0.84853493 |
| 64 | PRKCQ | 0.83904416 |
| 65 | EIF2AK2 | 0.82311913 |
| 66 | TGFBR2 | 0.80415141 |
| 67 | TAOK3 | 0.79332703 |
| 68 | TTN | 0.77303256 |
| 69 | CDK12 | 0.73642572 |
| 70 | ERN1 | 0.71725878 |
| 71 | CDK4 | 0.71299695 |
| 72 | CCNB1 | 0.69336594 |
| 73 | PIK3CG | 0.68794790 |
| 74 | ARAF | 0.67669673 |
| 75 | IRAK3 | 0.65597017 |
| 76 | CHUK | 0.63028868 |
| 77 | FGR | 0.59531792 |
| 78 | TAOK2 | 0.58808863 |
| 79 | PDGFRB | 0.57159513 |
| 80 | MAPK11 | 0.57089785 |
| 81 | ICK | 0.55139444 |
| 82 | HIPK2 | 0.54761240 |
| 83 | NEK2 | 0.54217428 |
| 84 | CDK6 | 0.53497310 |
| 85 | RPS6KA6 | 0.52438241 |
| 86 | ALK | 0.51122092 |
| 87 | TRPM7 | 0.49350971 |
| 88 | UHMK1 | 0.48719842 |
| 89 | MAPK7 | 0.48517435 |
| 90 | MAP3K1 | 0.48457167 |
| 91 | EIF2AK3 | 0.48027574 |
| 92 | SIK3 | 0.47916977 |
| 93 | MAP3K7 | 0.47489055 |
| 94 | MAP2K6 | 0.46507792 |
| 95 | TAOK1 | 0.46153792 |
| 96 | MAP3K6 | 0.46097030 |
| 97 | PDK1 | 0.45660515 |
| 98 | MELK | 0.45543764 |
| 99 | RPS6KL1 | 0.45158250 |
| 100 | RPS6KC1 | 0.45158250 |
| 101 | DAPK1 | 0.44801342 |
| 102 | BRAF | 0.44431693 |
| 103 | SGK3 | 0.43912631 |
| 104 | BMX | 0.43209470 |
| 105 | STK4 | 0.42988912 |
| 106 | MAP3K12 | 0.42912201 |
| 107 | MAP2K2 | 0.42351140 |
| 108 | YES1 | 0.40685348 |
| 109 | PAK1 | 0.38283898 |
| 110 | MAP3K8 | 0.37998844 |
| 111 | MAP3K3 | 0.37048207 |
| 112 | EPHA3 | 0.36241032 |
| 113 | PIM2 | 0.35967689 |
| 114 | AURKA | 0.35571303 |
| 115 | MARK2 | 0.33534045 |
| 116 | INSR | 0.33176626 |
| 117 | DYRK1B | 0.32958924 |
| 118 | STK24 | 0.31509861 |
| 119 | MAPK4 | 0.30574339 |
| 120 | MAPK3 | 0.30224413 |
| 121 | MATK | 0.29445138 |
| 122 | FYN | 0.29318164 |
| 123 | SGK2 | 0.29021887 |
| 124 | CDK7 | 0.28785043 |
| 125 | MAPKAPK2 | 0.27748933 |
| 126 | PDPK1 | 0.27289196 |
| 127 | RPS6KB2 | 0.26110799 |
| 128 | SCYL2 | 0.26097750 |
| 129 | PTK6 | 0.25602627 |
| 130 | MTOR | 0.25041944 |
| 131 | DMPK | 0.24799960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.22933570 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.26709050 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.98953394 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.93149417 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.64739821 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.48138345 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.32130371 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.28508632 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.16201857 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.15885495 |
| 11 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.07939468 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06764657 |
| 13 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.06642004 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02924405 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.00812747 |
| 16 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.92893512 |
| 17 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.89968830 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.81625174 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.78058043 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.73134507 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.72996618 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.69763859 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.63042136 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50372462 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.49008546 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47365376 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45364073 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.44416583 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42613192 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.41210644 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.38999844 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36335736 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36181341 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.30119634 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26388776 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14766460 |
| 37 | Mismatch repair_Homo sapiens_hsa03430 | 1.14114409 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.13880362 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.13017382 |
| 40 | Base excision repair_Homo sapiens_hsa03410 | 1.12899855 |
| 41 | DNA replication_Homo sapiens_hsa03030 | 1.12294961 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.12254745 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10502124 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.09693072 |
| 45 | Ribosome_Homo sapiens_hsa03010 | 1.09678083 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.09625204 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.08680141 |
| 48 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.08377604 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07845968 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06767558 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05375421 |
| 52 | HTLV-I infection_Homo sapiens_hsa05166 | 1.02480990 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 1.00816943 |
| 54 | Colorectal cancer_Homo sapiens_hsa05210 | 0.99787908 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97811453 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97258686 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96078031 |
| 58 | Tuberculosis_Homo sapiens_hsa05152 | 0.92186296 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.89242728 |
| 60 | Malaria_Homo sapiens_hsa05144 | 0.88940874 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88110384 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 0.87410755 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86258690 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.82767762 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82376942 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.78769573 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78707833 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.78469885 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78078736 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76443331 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.74510349 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73476887 |
| 73 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70569243 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70072187 |
| 75 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69991033 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.69855966 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68569458 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68196867 |
| 79 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67632145 |
| 80 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.66990965 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63128646 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62216847 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61938154 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59316406 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58897934 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.58705826 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58327398 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53740277 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50526658 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49955117 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.49025331 |
| 92 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.47997518 |
| 93 | Homologous recombination_Homo sapiens_hsa03440 | 0.47270997 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46025947 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45348246 |
| 96 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45164108 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45021134 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43413043 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43393452 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43324541 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41998826 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39948847 |
| 103 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.39514687 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.38177401 |
| 105 | RNA degradation_Homo sapiens_hsa03018 | 0.38033594 |
| 106 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.37473546 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.37208180 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34214418 |
| 109 | RNA transport_Homo sapiens_hsa03013 | 0.33832729 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33809436 |
| 111 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32863471 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.32295614 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31570189 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30853992 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30761761 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.30606902 |
| 117 | Cell cycle_Homo sapiens_hsa04110 | 0.30351640 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.29634657 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29347082 |
| 120 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28734629 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28593031 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.28340603 |
| 123 | Pathways in cancer_Homo sapiens_hsa05200 | 0.27604051 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.25355831 |
| 125 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.25307603 |
| 126 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.23954940 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.23575731 |

